El tratamiento psicologico del trastorno por angustia

Autores/as

  • Rafael Ballester Arnal Universitat Jaume I de Castelló
  • Cristina Botella Arbona Universitat Jaume I de Castelló

DOI:

https://doi.org/10.33898/rdp.v5i17.1057

Palabras clave:

trastorno por angustia, tratamiento del trastorno por angustia, cognitivo conductual

Resumen

En este artículo se pasa revista a las distintas concepciones y formas de tratamiento del trastorno por angustia, desde el modelo biológico y fisiológico al psicológico, especificando claramente los procedimientos a seguir en el marco de un enfoque cognitivo-conductual.

Descargas

Citas

Acierno, R.E.; Hersen, M. & Van Hasselt, V.B. (1993). Interventions for panic disorder: a critical review of the literature. Clinical Psychology Review. vol 13, 561-578.

Alfonso, S. (1987). Miedo, pánico y trastorno de ataques de angustia (panic disorder): aspectos conceptuales e históricos. Psiquis, vol VIII.

American Psychiatric Association (1980): Diagnosis and statistical manual of mental disorders. Washington D.C.: A.P.A. En castellano, traducido en editorial. Mason.

American Psychiatric Association (1988): Diagnosis and statistical manual of mental disorders. DSM-III Revisado. Washington D.C.: A.P.A. En castellano, traducido en editorial. Mason.

Appleby, T.L., Klein, D.F., Sachar, E.J. & Levitt, M. (1981): Biochemical indices of lactate-induced panic: a preliminary report. In D.F. Klein & J.G. Rabkin (eds): Anxiety: New Research and Changing Concepts, 411-423. New York: Raven Press.

Aronson, T.A. (1987). A naturalistic study of imipramine in panic disorder and agoraphobia. American Journal of Psychiatry, 144, 1014-1019.

Avia, MD (1986). Hiperventilación, ansiedad persistente y control respiratorio. Análisis y Modificación de Conducta, 12, 347-367.

Ayuso, J.L. (1988). Trastornos de angustia. Barcelona: Martinez Roca.

Ballenger, J. (1990). Efficacy of benzodiazepines in panic disorder and agoraphobia. Journal of Psychiatric Research. vol 24, 15-25.

Ballester, R. & Botella, C. (1992a). Aplicación del paquete cognitivo-conductual de Clark a un caso con trastorno de pánico. Psicothema vol 4, nº2, 69-88.

Ballester R. & Botella, C. (1992b). Aplicación en grupo del programa cognitivo-comportamental de Clark y Salkovskis: una alternativa para el tratamiento del pánico. Análisis y Modificación de Conducta vol 18, nº 58, pag 291-321.

Ballester, R., Botella, C., & GIL, MD. (1991). Los efectos diferenciales de la hiperventilación en pacientes con trastorno de pánico y un grupo control. II Congres Internacional “Latini dies”. Sitges, del 2 al 4 de Mayo.

Ballester, R., Botella, C., Gil, M.D. & Romero, R.(1991) Relación entre la respuesta a la hiperventilación y el grado de hipocondria en pacientes con pánico y un grupo control. I Simposium Nacional de Psicología Conductual. Jaen, del 1 al 5 de Abril.

Ballester, R. & Botella, C. (en prensa). Therapeutic effectiveness of cognitive-behavioral treatment of panic. Behavioral Psychotherapy.

Ballester, R. & Botella, C. (en preparación). Efecto de un programa cognitivo-comportamental sobre la conducta de enfermedad de pacientes con trastorno por angustia.

Barlow, D.H. (1986). A psychological model of panic. In B.F. Shaw, F. Cashman, Z. Segal & T. Yallis (eds). Anxiety disorder: theory, diagnosis and treatment. New York: Plenum.

Barlow, D.H. (1988a). Anxiety and its disorders. The nature and treatment of anxiety and panic. New York: Guildford Press.

Barlow, D.H. (1988b). Future directions. En C.G.Last y M.Hersen (eds). Handbook of anxiety disorders. New York: Pergamon.

Barlow, D.H. & Cerny, J.A (1988). Psychological treatment of panic. New York: Guildford Press.

Barlow, D.H., Craske, M.G., Cerny, J.A. & KLOSKO, J.S. (1989). Behavioral treatment of panic disorder. Behavior Therapy, 20, 261-282.

Barlow, D.H., Vermileya, J., Blanchard, E.B., Vermileya, B., Dinardo, P. & Cerny, J.A. (1985). The phenomenon of panic. Journal of Abnormal Psychology, 94, 320-328.

Beck, A.T. (1988) Cognitive approaches to panic disorder: theory and therapy. In S. Rachman and J.D. Maser (Comps). Panic: Psychological Perspectives. Lawrence Erlbaum Associates. New Jersey.

Beck, A.T, Emery, G. & Greenberg, R. (1985). Anxiety disorders and phobias. A cognitive perspective. New York, Basic Books.

Beck, A.T., Lande, R., & Bohnert, M. (1974). Ideational components of anxiety neurosis. Archs.Gen.Psychiat, 31, 319-325.

Botella, C. (1992). Las crisis de angustia. Proyecto de Investigación. Universidad de Murcia.

Botella, C., & Ballester, R. (1991). Tratamiento psicológico del trastorno de pánico: adaptación del programa cognitivo-conductual de Clark. Análisis y Modificación de Conducta, vol 17, 56, 871-894.

Bowlby, J. (1969). Attachement and loss: Vol I, Attachement. New York: Basic Books.

Bowlby, J. (1973). Attachement and loss: Vol II, Separation, anxiety and anger. New York: Basic Books.

Boyd, J.H. (1991). Westphal’s agoraphobia. Journal of Anxiety disorders, 5, 77-86.

Burrows, G. (1990). Managing long-term therapy for panic disorder. Journal of Clinical Psychiatry., vol 51 (11).

Burrows, G., Norman, T., Judd, F. & Marriott, P. (1990). Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders. Journal of Psychiatric Research, vol 24, 65-72.

Caballo, V. (1993). Avances en los trastornos por ansiedad: una entrevista con D.H. Barlow. Psicología Conductual, vol1, nº2, 291-300.

Chambless, D.L. & Gillis, M.M. (1993). Cognitive Therapy of anxiety disorders. Journal of Consulting and Clinical Psychology. vol 61, nº2, pag 248-260

Charney, D., Heminger, G. & Breier, A. (1984). Noradrenergic function in panic anxiety: effects of Yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry, 41, 751-763.

Charney, D., Heminger, G. & Jatlow, O. (1985). Increased anxiogenia effects of caffeine in panic disorders. Archives of General Psychiatry, 42, 233-243.

Clark, D.M. (1979); Therapeutic aspects of increasing pCO2 by behavioral means. Unpublished, M.Phil.Thesis. University London.

Clark, D.M. (1986). A cognitive approach to panic. Behavioral Research and Therapy, 24, 461-470

Clark, D.M. (1988). A cognitive model of panic attacks. En S. Rachman y J.D. Maser (Comps.). Panic: Psychological perspectives. New Jersey: Lawrence Erlbaum Associates.

Clark, D.M. & Hemsley, DR. (1982). The effects of hyperventilation: individual variability and its relation to personality. Journal of Behavior Therapy and Experimental Psychiatry. Vol. 25, 5, pp. 411-423.

Clark, DM & Salkowskis, PM. (1987). Cognitive treatment for panic attacks: Therapist’s manual. Manuscrito no publicado.

ClarkK, DM., Salkowskis, PM., Chalkley, A.J. (1985). Respiratory control as a treatment for panic attacks. Journal of behaviour therapy and experimental psychiatry, 16, 23-30.

Clark, D.M.; Salkowskis, P.M.; Hackman, A. & Gelder, M. (1991). Long-term outcome of cognitive therapy for panic disorder. Paper presented at the 25th annual meeting of the association for the advancement of behaviour therapy. New York. November.

Clark, D.M., Salkowskis, P., Gelder, M., Koehler, C., Martin, M., Anastasiades, P.,

Hackman, A., Middleton, H. & Jeavons, A. (1988): Tests of a cognitive theory of panic. En I. Hand & H.V.Wittchen (eds). Panic and Phobias, II. Berlin: Springer-Verlag.

Clum, G.A.; Clum, G.A. & Surls, R. (1993). A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology, vol 61, nº2, pag 317-326.

Craske, M.G., Brown, T.A. & Barlow, D.H. (1991). Behavioral treatment of panic disorder: a two year follow-up. Behaviour Therapy, 22, 289-304.

Deltito, J., Argyle, N., & Klerman, G. (1991). Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. Journal of Clinical Psychiatry, vol 52(3), 121-127.

Dupont, R. (1990). Thinking about stopping treatment for panic disorder. Journal of Clinical Psychiatry, vol 51, 38-45.

Echeburua, E. (1992). Avances en el tratamiento psicológico de los trastornos de ansiedad. Madrid: Pirámide

Ehlers, A. & Margraf, J. (1989). The psychopsysiological model of panic attacks. In P.Emmelkamp, W.Everaerd, F.Kraaimaat y M.vanSoon (eds): Fresh Perspectives on anxiety disorders. Lisse: Swets & Zeitlinger.

Ehlers, A., Margraf, J. & Roth, W.T. (1988). Interaction of expectancy and stressors in a laboratory model of panic. In C. Hellhammer, J. Florin & H. Weiner (eds). Neurobiological approaches to human disease, 379-384. Toronto: Huber.

Ehlers, A., Margraf, J., Roth, W., Taylor C.B., Maddock, R., Sheikh, J., Kopell, M., McClenahan, K., Gossard, D., Blowers, G., Agras, W. & Kopell, B. (1986c). Lactate infusions and panic attacks: do patients and controls respond differently?. Psychiatry Research, 17, 295-308.

Freud, S. (1895). Estudios sobre histeria. Obras Completas. Ed. Orbis (1988).

Fyer, A.T., Liebowitz, M. & Gorman, J. (1987). Discontinuation of alprazolam treatment in panic attacks. American Journal of Psychiatry., 144, 303-308.

Gittelman-Klein, R. & Klein, D.F. (1984). Relationship between separation anxiety and panic and agoraphobic disorders. Psychopathology (suppl), 17, 56-65.

Hibbert, G.A. (1984). Ideational components of anxiety. British Journal of Psychiatry, 144, 618-624.

Klein, D.F. (1964). Delineation of two-drug responsive anxiety syndromes. Psychopharmacologiea, 5, 397-408.

Klein, D.F. (1980). Anxiety reconceptualized. Comprehensive Psychiatry., 21, 411-427.

Klein, D.F. (1981). Anxiety Reconceptualized. In D.F. Klein & J. Rabkin: Anxiety: New Research and Changing Concepts. New York: Raven Press.

Klein, D.F., & Fink, M. (1962). Psychiatric reaction patterns to imipramine. American Journal of Psychiatry. Monogr., 2, 14-17.

Klein, D.F., Zitrin, C.M., Woerner, H., & Ross, D. (1983). Treatment of phobias II. Behavior therapy and supportive psychotherapy: are there any specific ingredients?. Archs.Gen.Psychiat, 40, 139-45.

Klein, E. & Metz, L. (1990). Differential drug response of panic and agoraphobic avoidance in a case of panic disorder. Acta Psychiatrica Scandinavica. vol 82(1), 86-87.

Klerman, G.L. (1988). Sources of current controversies in treatment of panic and phobia. En I.Hand and H.W. Witchen (eds): Panic and phobias 2. Treatment and variables affecting course and outcome.

Laberge, B.; Gauthier, J.G.; Cote, G.; Plamondon, J. & Cormier, H.J. (1993). Cognitivebehavioral therapy of panic disorder with secondary major depression: a preliminary investigation. Journal of Consulting and Clinical Psychology, vol 61, nº6, pag 1028-1037.

Ley, R. (1985). Agoraphobia, the panic attack and the hyperventilation syndrome. Behavioral research therapy, 23, 79-81.

Ley, R. (1987). Panic disorder: a hyperventilation interpretation. In L. Michelson & M. Ascher (eds): Cognitivebehavioral assessments and treatment of anxiety disorders. New York: Guilford.

Ley, R. (1988). Hyperventilation and lactate infusion in the production of panic attacks. Clinical Psychology Review, 8, 1-18.

Lum, L.C. (1976): The syndrome of habitual chronic hyperventilation. En O.W. Hill (ed): Modern trends in psychosomatic medicine (vol 3). London. Butterworths.

Mallol, J. (1987). Bioquímica de las crisis de angustia. Revista de Psiquiatría. vol XIV, pp. 36-41. Facultad de Medicina. Barcelona.

Margraf, J.; Barlow, D.H.; Clark, D.M. & Telch, M.J. (1993). Psychological treatment of panic: work in progress on outcome, active ingredients and follow-up. Behavioral Research and Therapy, 31, 1, 1-8.

Margraf, J., Ehlers, A. & Roth, W. (1986a). Biological models of panic disorder and agoraphobia: a review. Behavioral Research and Therapy, 24, 553-567.

Margraf, J., Ehlers, A. & Roth, W. (1986b). Sodium lactate infusions and panic attacks: a review and critique. Psychosomatic Medicine, 48, 23-51.

Margraf, J. & Schneider, S. (1991). Outcome and active ingredients of cognitive-behavioral treatments for panic disorder. Paper presented at the meeting of the Association for Advancement of Behavior Therapy, New York.

Mavissakalian, M. (1986). Imipramine in Agoraphobia. Comprehensive Psychiatry, 27, 401-406.

Mellergard, M., Lorentzen, K., Bech, P. & Ottosson, J. (1991). A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine. Acta Psychiatrica Scandinavica, vol 83, pp 28-32.

Mendel, J.G. & Klein, D.F. (1969). Anxiety attacks with subsequent agoraphobia. Comprehensive Psychiatry, 10, 190-195.

Michelson, L.K. & Marchione, K. (1991). Behavioral, cognitive and pharmacological treatments of panic disorder with agoraphobia: critique and synthesis. Journal of Consulting and Clinical Psychology. Vol. 59, 1, pp. 100-114.

Michelson, L., Marchione, K., Greenwald, M., Glanz, L., Testa, S., & Marchione, N. (1990). Panic disorder: cognitive-behavioral treatment. Behavioral Research and Therapy. Vol. 28, 2, pp 141-151.

Noyes, R., Garvey, M., Cook, B. & Suelzer, M. (1991). Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry. vol 184(4), 517-523.

Nutt, D. & Glue, P. (1991). Irritability in panic disorder: Effects of Imipramine treatment. Human Psychopharmacology Clinical & Experimental, vol 6(1), pp 49-52.

Oms (1992). CIE-10. Clasificación Internacional de los Trastornos Mentales y Comportamentales: Criterios Diagnósticos para la Investigación. Madrid: Editorial Meditor. Ost, L.G.; Westling, B.E. & Hellstrom, K. (1991). Applied relaxation exposure in vivo, and cognitive methods in the treatment of agoraphobia. Manuscript submitted for publication.

Oswald, I. (1966): Sleep. Harmondsworth: Penguin Books.

Pitts, F.N. Y McClure, J.N. (1967). Lactate metabolism in anxiety neurosis. New England Journal of Medicine, 277, 1329-1336.

Quitkin, F., McGrath, P., Stewart, J. & Harrison, W. (1990). Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Archives of General Psychiatry, vol 47(10), 935-941.

Rachman, S. & Maser, J. (1988). Panic: Psychological contributions. In S. Rachman and J.D. Maser (Comps). Panic: Psychological Perspectives. Lawrence Erlbaum Associates. New Jersey.

Rapee, R. (1986): The alleviation of panic attacks in the case of panic disorder. Journal of Behavior Therapy and Experimental Psychiatry, 16, 63-65.

Rapee, R. (1987). The psychological treatment of panic attacks: theoretical conceptualization and review of evidence. Clinical Psychology Review, 7, 427-438.

Rayney, J., Pohl, R., Williams, H., Kritter, E., Freedman, R. & Ettedgui, E. (1984). A comparison of lactate and isoprotenerol anxiety states. Psychopathology, 17 (suppl. I), 74-82.

Rijken, H.; Kraaimaat, F.; De Ruiter, C. & Garssen, B. (1992). A follow-up study on short-term treatment of agoraphobia. Behavioral Research and Therapy, 30, nº1, 63-66.

Rosenberg, R., Bech, P., Mellergard, M. & Ottosson, J. (1991). Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response. Acta Psychiatrica Scandinavica, vol 83, 46-52.

Salkovskis, P.M. Y Clark, D.M. (1986). Cognitive and physiological processes and treatment of panic attacks. En I.Hand y H. Wittchen (eds). Panic and phobias. Springer Verlag.

Salkovskis, P.M., JONES, D.R. & CLARK, D.M. (1986): Respiratory control in the treatment of panic attacks: replication and extension with concurrent measurement of behavior and pCO2. British Journal of Psychiatry, 148, 526-532.

Sandin, B. Y Chorot, P. (1991): Trastornos de pánico: consideraciones sobre su naturaleza, etiología y tratamiento. En G.Buela-Casal y V.E. Caballo (eds). Manual de Psicología Clínica Aplicada. Madrid: Sº XXI.

Sargant, W. (1962). The treatment of anxiety and atypical depression by the monoamine oxidase inhibitor drugs. Neuropsychiatry, 5, 96-103.

Shear, M., Ball, G., Josephson, ST. & Gitlin, B. (1988). Cognitive-Behavioral Treatment of Panic. In I.Hand & H.U. Wittchen: Panic and Phobias2. Springer-Verlag. 1988.

Sheehan, D.V. (1982). Panic Attacks and phobias. New England Journal of Medicine, 307, 156-158.

Sheehan, D.V. (1984). Strategies for diagnosis and treatment of anxiety disorders. In R. Pasnan (ed): Diagnosis and treatment of anxiety disorders. American Psychiatric Press. Washington.

Sheehan, D.V. (1987). Benzodiazepines in panic disorder. Journal of Affective Disorders, 13, 169-181.

Sheehan, D.V., BALLENGER, J.C. & JACOBSON, C. (1980). Treatment of endogenous anxiety with phobic histerical and hypochondrical symptoms. Archives of general psychiatry, 37, 51-59.

Sheehan, D., Raj, A., Harnett-Sheehan, K., & Soto, S. (1990). Adinazolam sustained release formulation in the treatment of panic disorder: a pilot study. Irish Journal of Psychological Medicine. Vol 7(2), 124-128.

Sheehan, D.V. & Sheehan, K.H. (1982a). The classification of anxiety and hysterical states. Part I: Historical review and empirical delineation. Journal of Clinical Psychopharmacology, 2, 235-244.

Sheehan, D.V. & Sheehan, K.H. (1982b). The classification of anxiety and hysterical states. Part II: Toward a more heuristic classification. Journal of Clinical Psychopharmacology, 2, 386-393.

Sokol-Kessler, L., Beck, A., Greenberg, R., Berchick, R., & Wright, F. (1989). Cognitive Therapy of panic disorder: a non pharmacological alternative. Journal of Nervous and Mental Disease, 177, 711-716.

Taylor, C. & Hayward, C. (1990). Cardiovascular considerations in selection of antipanic pharmacotherapy. Journal of Psychiatric Research., vol 24, 43-49.

Taylor, C., Sheikh, J., Agras, W., Roth, W., Margraf, J., Ehlers, A., Maddock, R.J. & Gossard, D. (1986). Ambulatory heart rates in panic attack patients. American Journal of Psychiatry. In press.

Tearman, B.H., Telch, H. & Keefe, P. (1984). Etiology and onset of agoraphobia: a critical review. Comprehensive Psychiatry, 25, 51-62.

Telch, M., Tearman, B. & Taylor, C. (1983): Antidepressant medication in the treatment of agoraphobia. A critical review. Behavioral Research and Therapy. 21, 505-517.

Tesar, G., Rosenbaum, J., Pollack, M. & Otto, M. (1991). Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. Journal of Clinical Psychiatry. vol 52(2), 69-76.

Tobeña, A., Sanchez, R., Pose, R. & Masana, J. (1990). Brief treatment with alprazolam and behavioral guidance in panic disorder. Anxiety Research. vol 3(3), 163-174.

Van Den Hout, M.A. & Griez, E. (1982). Cognitive factors in carbon dioxide therapy. Journal of Psychosomatic Research, 26, pp. 209-214.

Van Den Hout, M.A. & Griez, E. (1983). Some remarks on the nosology of anxiety states and panic disorders. Acta Psychiatrica Belga, 83, 33-42.

Wilson, G.T. (1987). Fear reductions methods and the treatment of anxiety disorders. En G.T. Wilson, C.M. Franks, P.C. Kendall y J.P. Foreyt (eds). Review of behavior therapy. Theory and practice. Vol II. New York: Guilford Press.

Zitrin, C.M., Klein, D.F. & Woerner, M.G. (1978). Behavior Therapy, supportive psychotherapy, imipramine and phobias. Archives of general psychiatry, 37, 63-72.

Zitrin, CM., Klein, DF., Woerner, MG. & Ross, DC. (1983): Treatment of phobias. Comparison of imipramine hidrochloride and placebo. Archives of general psychiatry, 40, 125-133.

Descargas

Publicado

1994-03-01

Cómo citar

Ballester Arnal, R., & Botella Arbona, C. (1994). El tratamiento psicologico del trastorno por angustia. Revista de Psicoterapia, 5(17), 85–112. https://doi.org/10.33898/rdp.v5i17.1057